Bo Li
- Cancer Research top 2%
- Hepatology top 2%
- Liver Disease and Transplantation 16
- Hepatocellular Carcinoma Treatment and Prognosis 11
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research 15
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies 10
- Genetics top 5%
- Mesenchymal stem cell research 10
-
- Organ Transplantation Techniques and Outcomes 22
- Cholangiocarcinoma and Gallbladder Cancer Studies 11
-
- Liver Disease Diagnosis and Treatment 15
- Cited by
- Cancer ResearchHepatologyOncology
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Bo Li
218 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 167
- Cancer Research 888
- Hepatology 337
- Oncology 989
- Otorhinolaryngology 127
- Genetics 309
Countries citing papers authored by Bo Li
This map shows the geographic impact of Bo Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Li more than expected).
Fields of papers citing papers by Bo Li
This network shows the impact of papers produced by Bo Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Li. The network helps show where Bo Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bo Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 0 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 0 | |
| 9 | 2024 | 6 | |
| 10 | 2024 | 22 | |
| 11 | 2024 | 3 | |
| 12 | 2024 | 4 | |
| 13 | 2024 | 8 | |
| 14 | 2024 | 8 | |
| 15 | 2023 | 1 | |
| 16 | 2023 | 2 | |
| 17 | 2023 | 36 | |
| 18 | 2023 | 1 | |
| 19 | 2019 | 7 | |
| 20 | 2014 | 1 |
About Bo Li
Bo Li is a scholar working on Hepatology, Otorhinolaryngology, Oncology, Surgery and Cancer Research, having authored 238 papers that have together received 4.3k indexed citations. Recurring topics across this work include Organ Transplantation Techniques and Outcomes (22 papers), Liver Disease and Transplantation (16 papers), Liver Disease Diagnosis and Treatment (15 papers), Pancreatic and Hepatic Oncology Research (15 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Head and Neck Cancer Studies (10 papers) and Mesenchymal stem cell research (10 papers). The work is most often cited by research in Cancer Research (888 citations), Hepatology (337 citations), Oncology (989 citations), Otorhinolaryngology (127 citations) and Genetics (309 citations). Bo Li has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Longjiang Li, Zhijie Weng, Chenzhou Wu, Yonggang Wei, Zhihe Zhao, Takehito Ouchi, Mingqing Xu, Bo Han, Bowen Zhang and Fanyuan Yu. Their work appears in journals such as Medicine, PLoS ONE, Frontiers in Oncology, Surgical Endoscopy and Journal of Surgical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.